Literature DB >> 19573287

Symposium: Update on prediction and management of OHSS. A modern classification of OHSS.

Abraham Golan1, Ariel Weissman.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication of ovarian stimulation using fertility medications. OHSS classification presents the different severity categories and grades of OHSS and optimizes management schemes and prognosis. An initial classification system, which grouped OHSS into mild, moderate and severe categories, was based on patients' symptomatology plus manual estimation of ovarian enlargement and urinary excretion of sex steroids. A revised classification system then also incorporated the use of transvaginal sonography for both estimation of ovarian enlargement and detection of even small amounts of ascitic fluid. The detection of ascites establishes the diagnosis of moderate OHSS which may deteriorate to a severe form and is therefore of major importance. Subsequent modifications defined a group of critical or complicated OHSS in which grave complications have already developed. A consensus on the classification of OHSS should be reached by professional societies. As the revised classification system is very valid and widely used, it should form the basis for a modern classification, with the addition of critical or complicated OHSS to the severe category of the syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19573287     DOI: 10.1016/s1472-6483(10)60042-9

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  28 in total

1.  Thoracic endometriosis unmasked by ovarian hyperstimulation for in vitro fertilization.

Authors:  Stephanie A C Halvorson; Mari A Ricker; Alan F Barker; Phillip E Patton; Rebecca A Harrison; Alan J Hunter
Journal:  J Gen Intern Med       Date:  2012-01-11       Impact factor: 5.128

2.  Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Ann Med Surg (Lond)       Date:  2022-06-25

3.  Risk of Higher Blood Pressure in 3 to 6 Years Old Singleton Born From OHSS Patients Undergone With Fresh IVF/ICSI.

Authors:  Yimin Zhu; Yanling Fu; Minyue Tang; Huanmiao Yan; Fanghong Zhang; Xiaoling Hu; Guofang Feng; Yu Sun; Lanfeng Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

4.  GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Ivy Maina; Clarisa Gracia; Anuja Dokras
Journal:  J Assist Reprod Genet       Date:  2016-06-27       Impact factor: 3.412

5.  Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study.

Authors:  George T Lainas; Efstratios M Kolibianakis; Ioannis A Sfontouris; Ioannis Z Zorzovilis; George K Petsas; Theoni B Tarlatzi; Basil C Tarlatzis; Trifon G Lainas
Journal:  Reprod Biol Endocrinol       Date:  2012-08-31       Impact factor: 5.211

6.  Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles.

Authors:  Srisailesh Vitthala; Jerome Bouaziz; Amanda Tozer; Ariel Zosmer; Talha Al-Shawaf
Journal:  Int J Endocrinol       Date:  2012-02-12       Impact factor: 3.257

7.  ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial.

Authors:  Sara Mokhtar; Mohammad Reza Sadeghi; Mohammad Mehdi Akhondi; Simin Zafardoust; Bita Badenush; Farnaz Fatemi; Fattane Nazari; Koorosh Kamali; Afsaneh Mohammadzade
Journal:  J Reprod Infertil       Date:  2015 Jul-Sep

8.  Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.

Authors:  Ali Abbara; Channa N Jayasena; Georgios Christopoulos; Shakunthala Narayanaswamy; Chioma Izzi-Engbeaya; Gurjinder M K Nijher; Alexander N Comninos; Deborah Peters; Adam Buckley; Risheka Ratnasabapathy; Julia K Prague; Rehan Salim; Stuart A Lavery; Stephen R Bloom; Matyas Szigeti; Deborah A Ashby; Geoffrey H Trew; Waljit S Dhillo
Journal:  J Clin Endocrinol Metab       Date:  2015-07-20       Impact factor: 5.958

9.  Hematocrit as a simple method to predict and manage ovarian hyperstimulation syndrome in assisted reproduction.

Authors:  Taswin Kaur; Praveena Pai; Pratap Kumar
Journal:  J Hum Reprod Sci       Date:  2015 Apr-Jun

10.  Predictive factors for recovery time in patients suffering from severe OHSS.

Authors:  Kazem Nouri; Clemens B Tempfer; Christian Lenart; Lisa Windischbauer; Katharina Walch; Regina Promberger; Johannes Ott
Journal:  Reprod Biol Endocrinol       Date:  2014-07-05       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.